Much like it was earlier in the month, S&P 500’s cousin—the Equal-Weighted Index—fared better than the S&P 500 index, continuing to indicate breadth in the market isn’t all defined by chips. Despite the cap-weighted index’s recent retreat, our technical gauges remain disciplined and fully invested.
History Rhymes: Is This the Townshend Act of 1767 All Over Again?
Nothing says "read the fine print" quite like a week where three separate bills land in the mailbox on the same stretch of days. The White House sent its invoice first — twice, actually — oil sent a supplemental charge, and the AI trade tacked on a surcharge nobody asked for after Wednesday's biggest earnings report of the week. Trade tension, the risk of higher inflation, and rising yields did the rest of the damage, and Wall Street spent the week doing the math and deciding the total was more than it wanted to spend. The receipt: the Dow's third straight losing week, and back-to-back losing weeks for both the S&P and Nasdaq.
For context: the Townshend Acts were Britain's 1767 tax on imported goods like glass, paper, and tea into the American colonies — a levy so unpopular it helped light the fuse on the American Revolution. Wall Street's version of the fuse this week was a little less flammable, but the tariff bill still landed with the same basic message: pay up, or else.
The Final Score
The S&P 500 slipped 0.6% on the week to close at 7,411.98, essentially flat on Friday itself but unable to shake a rough Wednesday and Thursday. The Nasdaq Composite took the harder hit, falling 2.1% to 24,975.82 — its worst weekly showing since late March — as Mega-cap tech names shed nearly $800 billion in combined market value in a single session Thursday.
Treasuries had the rougher week of all. The 10-year yield surged as high as 4.70% Thursday — its highest level since January 2025 — before easing back to around 4.69% by Friday's close. The 30-year climbed to 5.167%, its highest mark in roughly two months, and the 2-year jumped to 4.33%. Every one of those moves traces back to the same cause: trade tension, expensive energy, and inflation fear all charging the bond market at once, with traders now pricing in real odds the Fed hikes rates next week rather than holds steady — a plot twist nobody had on their bingo card a month ago.
The Tariff Invoice Arrives - Monday, President Trump imposed 50% tariffs on most Canadian goods, declaring that Canada has unfairly discriminated against American autos, alcohol, and dairy products. The new duties carved out exemptions for energy products, potash, fish, and critical minerals — but, notably, they also applied to goods that had previously been shielded from import taxes altogether under the United States-Mexico-Canada Agreement. In other words, this invoice didn't just raise the price; it tore up an old receipt that was supposed to be permanent.
Then, Friday, the second invoice arrived: the U.S. imposed new tariffs of 10% and 12.5% on goods from 60 trading partners, including the European Union and China, alleging those countries failed to curb the import of goods made with forced labor — the timing lining up precisely with the expiration of the prior 10% global tariff. It's the administration's second attempt to secure a durable legal footing for its trade agenda after the Supreme Court struck down the original framework in February, a ruling that had already forced roughly $81 billion in refunds. Whatever the legal label, the checkout total for importers looks strikingly similar to before, only now backed by a different receipt — and long Treasury yields took notice immediately, jumping more than 10 basis points on the news.
The AI Trade's Return Policy - If tariffs and oil weren't enough, the AI trade decided this was the week to send back some merchandise — and the return desk opened right on schedule Wednesday after the bell, when Google parent Alphabet reported earnings. The results themselves were strong: cloud revenue jumped 82% year-over-year, well ahead of whisper numbers in the 70-75% range. But investors fixated instead on the bill still to come — Alphabet raised its 2026 capital expenditure guidance from a range of $180-190 billion to $195-205 billion, and warned that 2027 spending would rise "significantly" from there. A great quarter, undercut by a bigger invoice for next year, was exactly the kind of receipt this market didn't want to see, and the stock's slide dragged the broader tech tape down with it. Intel piled on Friday, sliding nearly 8% despite delivering a blockbuster revenue forecast of its own — proof that in this market, good news isn't the same as good-enough news anymore. Sandisk tumbled another 11% on top of the prior week's losses.
The Data That Didn't Move the Needle (But Should Have) - Buried under the tariff and earnings headlines was a genuinely mixed batch of economic data. The Leading Economic Index fell 0.2%, missing expectations for a 0.2% gain. New home sales, on the other hand, came in better than expected at 628,000 against a 620,000 estimate. The S&P Global U.S. Manufacturing PMI ticked down to 53.8 from 53.9, below the 54.3 economists were looking for — still expansion territory, just softer than hoped. The one clean beat of the week came from the labor market: initial jobless claims fell 22,000 to 187,000, the lowest level since 1969, and well below the 212,000 economists expected, while continuing claims dropped to a seasonally adjusted 1.796 million. A resilient labor market, in other words, buried under three separate invoices that got all the attention instead.
Full Receipt - The FOMC meets Tuesday and Wednesday, and while a hold remains the base case, markets are now entertaining real hike odds — a sign of just how much this week's stacked invoices rattled the inflation outlook. Layered on top: Meta and Microsoft report Wednesday, Apple and Amazon report Thursday, meaning the market gets its next real-time referendum on AI spending discipline in the same 48 hours the Fed hands down its decision.
While The Odyssey has had Hollywood's full attention at the box office last week, the Fed chair's interest rate decision on July 29th will be Wall Street's real ticket office — the one event this week that determines whether this was a one-time surcharge or the start of a much longer subscription. The S&P remains within striking distance of its June record, the labor market is arguably as healthy as it's been since the Nixon administration, and the economy is still humming by most measures. But this was a week when trade tensions, rising yields, and a capex-driven AI sell-off all arrived at once — and the market's response was to pay up, grumble, and check the total twice.
“The specific authorities this Administration is using have changed, but the trade strategy has not. Specifically, we are continuing to impose tariffs and negotiate deals to support the reindustrialization of our economy, protect American workers and increase their wages, and shrink our trade deficit."
- U.S. Trade Representative Jamieson Greer, Senate Finance Committee, July 22, 2026
Perspectives by Fiona Zhang
UNH: A Better Hand? A Better Player
Imagine sitting down at a poker table and being dealt a difficult hand. The cards are not what you were hoping for. As the people watching begin to see the situation unfold, the conversation quickly turns to the odds stacked against you. The sighs get louder, the confidence fades, and many begin to wonder whether there is any path to victory at all.
That was UnitedHealth's challenge coming into 2026.
The company was still facing many of the same concerns that had pressured the stock in 2025. Rising healthcare utilization, higher medical costs, and uncertainty around Medicare Advantage reimbursement had created a difficult backdrop for the entire managed care industry. Proposed changes to Medicare Advantage payment rates suggested that government payments to insurers could grow less favorably than previously expected, raising concerns that reimbursement growth may not keep pace with rising healthcare costs. The concern was straightforward: if the cost of providing care continued to rise faster than the payments insurers received, profit margins would come under pressure.
Source: 1 - Google Finance
Investors had seen this story before. In 2025, when medical costs accelerated faster than expected, UnitedHealth struggled to adjust quickly enough. Earnings expectations were reset, guidance was lowered, and confidence in the company's ability to navigate the environment took a major hit.
The market remembered that disappointment.
So when similar concerns resurfaced, investors were quick to assume the worst. The market was quick to revisit the fears from the previous year, and investors rushed to reduce exposure as uncertainty grew. Shares fell sharply, declining nearly 20% in a single day in late January 2026 as the market reacted to the possibility that the business's challenges could persist longer than expected.
Under such pressure, the early progress UnitedHealth had made in rebuilding confidence after the 2025 setback was suddenly at risk of being swept away. The market's cautious optimism faded quickly, and concerns grew that the company's recovery story could be losing momentum before it had a chance to develop fully.
Then came the unexpected turn.
It’s not that the cards suddenly changed. Healthcare costs were still elevated. Medicare Advantage remained under pressure. The policy environment was still evolving. But this time, UnitedHealth played the hand differently.
Rather than allowing industry headwinds to overwhelm results, management demonstrated stronger execution. Part of that stronger execution came from difficult strategic decisions made over the previous year. Rather than chasing membership growth at any cost, the company exited unprofitable markets, reduced exposure to lower-margin businesses, and resized its Medicare Advantage membership. These actions helped improve operating efficiency and protect margins. Compared with 2025 Q4, 2026 Q1 earnings showed a noticeable decline in operating costs, while the business mix also shifted, with a lower share of risk-based customers and a higher share of fee-based customers. The company showed better control over medical costs, maintained resilience across its businesses, and benefited from the diversification and scale of Optum, which continued to provide support beyond traditional insurance operations. The final Medicare Advantage reimbursement environment also proved more manageable than investors had initially feared, easing some of the pressure weighing on sentiment. These operational changes suggested that UnitedHealth had become more disciplined in allocating capital and managing risk, helping explain why earnings rebounded so sharply from the previous quarter.
The result was a message the market had been waiting for: the problem was never that UnitedHealth couldn't operate in a difficult environment. The question was whether it could adapt quickly enough. The spotlight shifted from the cards on the table to the player making the calls. The same challenges that once sparked fears of a deeper problem became evidence of the company's ability to navigate uncertainty. And perhaps that's what the market realized all along. In markets, as in life, success is not always about being dealt perfect cards. It is more often about making the right decisions with the cards you have. After stumbling with a difficult hand in 2025, UnitedHealth showed investors in 2026 that it had learned how to play the game, even when dealt a challenging hand. In the long run, as economists always like to remind us, luck may win a pot, but skill is what survives the night.
Advisory services offered through Sowell Management, a Registered Investment Advisor. The views expressed represent the opinion of Sowell Management. The views are subject to change and are not intended as a forecast or guarantee of future results. This material is for informational purposes only. It does not constitute investment advice and is not intended as an endorsement of any specific investment. Stated information is derived from proprietary and non-proprietary sources that have not been independently verified for accuracy or completeness. While Sowell Management believes the information to be accurate and reliable, we do not claim or have responsibility for its completeness, accuracy, or reliability. Statements of future expectations, estimates, projections, and other forward-looking statements are based on available information and Sowell Management’s view as of the time of these statements. Accordingly, such statements are inherently speculative as they are based on assumptions that may involve known and unknown risks and uncertainties. Actual results, performance or events may differ materially from those expressed or implied in such statements. Investing in securities involves risks, including the potential loss of principal. While equities may offer the potential for greater long-term growth than most debt securities, they generally have higher volatility. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Past performance is not indicative of future results.
You should receive a confirmation email shortly. Don’t forget to reserve your room through the unique Sowell hotel reservation page. You can extend your stay at the Sowell Summit reduced room rate.
WEEK AHEAD
July 27-31, 2026
Weekly Market Commentary:
History Rhymes: Is This the Townshend Act of 1767 All Over Again?
The Final Score
Perspectives by Fiona Zhang
UNH: A Better Hand? A Better Player
Advisory services offered through Sowell Management, a Registered Investment Advisor. The views expressed represent the opinion of Sowell Management. The views are subject to change and are not intended as a forecast or guarantee of future results. This material is for informational purposes only. It does not constitute investment advice and is not intended as an endorsement of any specific investment. Stated information is derived from proprietary and non-proprietary sources that have not been independently verified for accuracy or completeness. While Sowell Management believes the information to be accurate and reliable, we do not claim or have responsibility for its completeness, accuracy, or reliability. Statements of future expectations, estimates, projections, and other forward-looking statements are based on available information and Sowell Management’s view as of the time of these statements. Accordingly, such statements are inherently speculative as they are based on assumptions that may involve known and unknown risks and uncertainties. Actual results, performance or events may differ materially from those expressed or implied in such statements. Investing in securities involves risks, including the potential loss of principal. While equities may offer the potential for greater long-term growth than most debt securities, they generally have higher volatility. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Past performance is not indicative of future results.